The company Walmark was established in 1990. After initial foreign business activities within the information technology trade and household utensils, the company started focusing on the trade with agricultural products, particularly the export of special seeds for food industry. 
In the second half of 1991, it commenced its business activities and then the production (1993) within the segment of alcohol free beverages. From 1992, the company started to import and then produce pharmaceutical and pharmaceutical formulas, particularly food supplements and healing cosmetics. The three specified business segments formed three divisions and until September 2001, they represented basic parts within the company structure.
The organization structure and management mechanisms continuously adjust to the new requirements resulting from the company fast development. On 01.06.2001, the general meeting have decided to change the legal form from the limited liability company to joint-stock company.
In 2001 the Company Management adopted a decision about the strategic orientation of the company towards pharmacy, which is a field with high prospects of growth, both in domestic and international respect. In relation to the above decision, in September of the same year the agricultural products division was sold, and in the end of 2004 the food division was sold.
The achieved finances helped the company to invest into the development of pharmaceutical division. The company built a new production plant complying with the GMP standards (Good Manufacturing Practice), which ranks amongst the most modern in the CR. From 2003, based on successfully managed certification process, Walmark is a holder of permit to produce medicines issued by the State institute for drug control. A significant turning point for further development was the commencement of production of first medicines in September 2004. The original portfolio of food supplements, currently offering one of the most extended and unified product range on the Czech market, was extended with humane medicines.
These divesting processes were accompanied by acquisition processes in areas related to the pharmaceutical production and healthy life style. The areas providing a real synergic effects and larger potential for further expansion even on international level. After the take-over of the company Profitness, a.s. in January 2005, running a chain of Vitaland stores for healthy lifestyle, we gained the majority in the company Aminostarin 2006, which is one of the prominent Czech producers of food supplements and nutrition for athletes, and in 2008 we gained 100 % share in the company.
The consolidated turnover of Walmark holding in the last financial year (June 2010 - May 2011) reached the level of 97,1 mil. EUR (2,4 bil. CZK). In the same time period Walmark holding has employed 882 employees in Czech Republic and in its 8 foreign subsidiaries.